Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chaney

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|September 1, 1988
Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitroS K Mauldin, M Plescia, F A Richard, et al.
Cancer Research|July 1, 1994
Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell linesE L Mamenta, E E Poma, W K Kaufmann, et al.
Anticancer Research|January 1, 1988
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactonesI H Hall, W L Williams, A A Grippo, et al.
Biochimica Et Biophysica Acta|July 27, 1981
Mechanism of eukaryotic protein synthesis inhibition by brusatolW Willingham, E A Stafford, S H Reynolds, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trialW P Petros, S G Chaney, D C Smith, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 27, 1999
Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat modelJ Holmes, J Stanko, M Varchenko, et al.
Biochemistry|August 25, 1999
Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adductsA Vaisman, S E Lim, S M Patrick, et al.
Toxicology|November 1, 1990
Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 miceI H Hall, A A Grippo, D J Holbrook, et al.
Journal of Pharmaceutical Sciences|February 1, 1988
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivoW L Williams, I H Hall, A A Grippo, et al.
Cancer Research|August 29, 1998
The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adductsA Vaisman, M Varchenko, A Umar, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|September 1, 1988
Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitroS K Mauldin, M Plescia, F A Richard, et al.
Cancer Research|July 1, 1994
Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell linesE L Mamenta, E E Poma, W K Kaufmann, et al.
Anticancer Research|January 1, 1988
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactonesI H Hall, W L Williams, A A Grippo, et al.
Biochimica Et Biophysica Acta|July 27, 1981
Mechanism of eukaryotic protein synthesis inhibition by brusatolW Willingham, E A Stafford, S H Reynolds, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trialW P Petros, S G Chaney, D C Smith, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 27, 1999
Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat modelJ Holmes, J Stanko, M Varchenko, et al.
Biochemistry|August 25, 1999
Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adductsA Vaisman, S E Lim, S M Patrick, et al.
Toxicology|November 1, 1990
Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 miceI H Hall, A A Grippo, D J Holbrook, et al.
Journal of Pharmaceutical Sciences|February 1, 1988
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivoW L Williams, I H Hall, A A Grippo, et al.
Cancer Research|August 29, 1998
The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adductsA Vaisman, M Varchenko, A Umar, et al.
Pageof 9